BRIEF-Resverlogix provides groundbreaking results in patients with severe kidney impairments
January 23, 2017 at 07:41 AM EST
* Announced preliminary results from New Zealand based Phase 1 trial with severe kidney (renal) impaired patients Source text for Eikon: Further company coverage:
